Institute For Medical Research Inc is located in Durham, NC. The organization was established in 1989. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 09/2023, Institute For Medical Research Inc employed 155 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Medical Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2023, Institute For Medical Research Inc generated $20.8m in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 30.9% each year . All expenses for the organization totaled $15.8m during the year ending 09/2023. While expenses have increased by 24.3% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO SUPPORT RESEARCH AND EDUCATION THROUGHOUT THE DURHAM VETERANS AFFAIRS HEALTH CARE SYSTEM.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SUPPORTED A MEDICAL TRAINING AND EDUCATION PROGRAM TO SUPPORT THE VA PHARMACOGENOMICS ACTION FOR CANCER SURVIVORSHIP (PHASER). EXPANDED ACCESS TO PHARMACOGENOMIC (PGX) TESTING, INCLUDING PROVIDING BASIC PGX EDUCATION, TO AN ADDITIONAL 10,000 VETERANS SEEN ACROSS 25 VA HEALTH CARE SYSTEMS NATIONWIDE. ENGAGED IN PHARMACOGENOMIC EDUCATION WITH APPROXIMATELY 1,000 NEW VA PROVIDERS IN ADDITION TO HOSTING MONTHLY PGX BROWN BAG LEARNING SESSIONS AND RELEASING A MONTHLY PGX NEWSLETTER TO OVER 1,700 CLINICIANS. SECURED COMMITMENTS FROM ANOTHER 27 VA HOSPITALS TO IMPLEMENT THE PHASER PGX TESTING PROGRAM. BUILT AND RELEASED NATIONALLY AUTOMATED CLINICAL DECISION SUPPORT TOOLS FOR DRUG-GENE ALERTS FOR ALL STATINS AND SELECT SSRIS, NSAIDS, PPIS, CLOPIDOGREL, ONDANSETRON, AND LOOK TO HAVE RELEASED BEFORE THE END OF THE CALENDAR YEAR ALERTS TO SUPPORT DRUG-GENE ALERTS FOR SELECT TCAS, ATOMOXETINE, PHENYTOIN, TACROLIMUS, TAMOXIFEN, AND VORICONAZOLE. PREPARED THE EDUCATION AND TECHNICAL ENVIRONMENTS FOR A TESTING PANEL EXPANSION FROM 11 TO 15 GENES DUE TO BE RELEASED BY THE END OF THE CALENDAR YEAR.
SUPPORTED NUMEROUS PROJECTS TO FURTHER AID WITH THE DIAGNOSIS, RISK STRATIFICATION AND LIFE STYLE INTERVENTION FOR THE BENEFIT OF UROLOGY AND ONCOLOGY PATIENTS.
ACCOMODATED MAJOR GROWTH OF A PROSTATE CANCER PROGRAM TO ADD MULTIPLE PROJECTS, ADDING THOUSANDS OF PATIENTS AND NEW AVENUES OF PATIENT EDUCATION AND POTENTIAL TREATMENT.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Liana Puscas MD Secretary/tr | OfficerTrustee | 2 | $0 |
Kenneth Goldberg MD Vice Preside | OfficerTrustee | 2 | $0 |
David Edelman MD President | OfficerTrustee | 5 | $0 |
Alyshia Smith Dnp Director | Trustee | 2 | $0 |
Jeffrey Smith Fmr Ex Dir | Officer | 40 | $93,956 |
Name Not Listed Frac CFO | Officer | 16 | $13,020 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $20,502,761 |
Investment income | $113,852 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $20,756,676 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $190,195 |
Compensation of current officers, directors, key employees. | $190,195 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $9,173,981 |
Pension plan accruals and contributions | $118,518 |
Other employee benefits | $933,922 |
Payroll taxes | $710,394 |
Fees for services: Management | $0 |
Fees for services: Legal | $67,622 |
Fees for services: Accounting | $24,500 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $1,422,747 |
Advertising and promotion | $1,062 |
Office expenses | $155,843 |
Information technology | $135,601 |
Royalties | $0 |
Occupancy | $254,556 |
Travel | $90,738 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $66,866 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $22,335 |
All other expenses | $0 |
Total functional expenses | $15,766,250 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,724,240 |
Savings and temporary cash investments | $1,746,984 |
Pledges and grants receivable | $6,433,373 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $119,747 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $1,960,000 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $1,088,582 |
Total assets | $13,072,926 |
Accounts payable and accrued expenses | $1,260,111 |
Grants payable | $0 |
Deferred revenue | $2,280,985 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,095,452 |
Total liabilities | $4,636,548 |
Net assets without donor restrictions | $7,169,582 |
Net assets with donor restrictions | $1,266,796 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $13,072,926 |